Intragastric Balloon Market Size, Share & Industry Analysis, By Product Type (Single Intragastric Balloon, Dual Intragastric Balloon, Triple Intragastric Balloon), By Filling Material Type (Saline-filled, Gas-filled ) By End User (Hospitals, Clinics, Others) Others and Regional Forecast, 2021-2028

Intragastric balloon placement is a weight loss procedure which includes the placing of a saline filled or gas filled balloon inside the stomach of an individual. The placement of an intragastric balloon helps lose weight, thus eliminating the risk of chronic heart diseases or stroke and high blood pressure. Growing prevalence of obesity across the globe is one of the major factor augmenting growth of Intragastric balloon market. Adoption of sedentary lifestyle coupled with increasing habit of alcohol consumption are leading to the growing incidence of obesity. For instance, as per World Health Organization (WHO), in 2016, more than 1.9 billion adults were over weight. Hence, growing incidence of obesity will strongly impact the growth of intragastric balloon market across the forecast period.'

Key Market Driver -

Growing prevalence of obesity will significantly boost market growth

Key Market Restraint -

Stringent government regulations for approval of such procedure

The major factor expected to drive the intragastric balloon market is growing prevalence of obesity across various regions of the world. Moreover, increasing technological advancements pertaining to intragastric balloon procedures is  another chief factor stimulating makret growth. The intragastric balloon placement procedure is associated with significant efficacy in relief of comorbid disease symptoms through body weight reduction. Anatomically, this proceudre is based on gastric space-occupying effects that rises the feeling of satiety and also affect gut neuroendocrine signaling. Technolgical enhancements associated with these intragastric balloons include the integration of dual and triple balloons to prevent migration of the device from the stomach to the intestines if a balloon deflation occurs, thus reducing the risk of intestinal obstruction. Moreover, increasing awareness and growing preference among the population for minimally invasive procedures, owing to its shorter recovery time span is another significant factor propelling market growth.

However, lack of awareness regarding obesity, especially in emerging countries is limiting the number of patients undergoing the procedure. This is prime factor limiting the growth of the intragastric balloon market. Additionally, side effects such as abdominal or back pain, acid reflux or indigestion, associated with intragastric balloon placement procedures might restrict market growth across the forecast period.

Market Segmentation:

By product type, the market is segmented into single intragastric balloon, dual intragastric balloon and triple intragastric balloon.

Based on filling material the market is classified as saline-filled and gas-filled balloons. Furthermore, based on end-user the market is bifurcated into hospitals, ambulatory surgical centers, clinics and others.

From a geographical standpoint, the market is categorized into North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa.

Key Players Covered:

The major companies in the global intragastric balloon market report includes Allurion Technologies Inc., Apollo Endosurgery, Inc., Districlass Médical, ENDALIS, Helioscopie Medical Implants, LEXEL S.R.L., EnteroMedics Inc. (ReShape Lifesciences, Inc). and others.  

Key Insights

• Technological advancements pertaining to intragastric balloon placement


• Regulatory Scenario, Key Countries, 2018


• Pipeline Analysis


• New Product Launches, Key Players

Regional Analysis:

To gain extensive insights into the market, Request for Customization

The global intragastric balloon market has been segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa. North America followed by Europe dominated the global intragastric balloon market in 2018, owing to increasing incidence of obesity across various countries of North America and Europe. Moreover, increasing number of major players entering the Asia Pacific region through various inorganic growth strategies will further augment market growth across the region. Also, Latin America and Middle East & Africa are projected to register a lucrative growth across 2018-2026, owing to growing awareness among the population about several benefits associated with intragastric balloon placement procedures.   

Segmentation

Intragastric Balloon Market Industry Developments

• In October 2017, EnteroMedics announced the acquisition of ReShape Medical. With the acquisition of the medical technology company, EnteroMedics Inc. has added the ReShape Dual weight loss balloon, to its product portfolio.


• In August 2015, Apollo Endosurgery, Inc. announced the U.S. Food and Drug Administration (FDA) approval of the ORBERA intragastric balloon to assist adult patients suffering from obesity. Novel product launch assisted the company to expand its product portfolio as well as serve a broader customer base.